Table 2.
Univariate comparison of in-hospital dynamic variables based on 30DRA
| Variable | Control | 30DRA | P-Value |
|---|---|---|---|
| SYSTOLIC BLOOD PRESSURE | |||
| Mean SBP (mmHg) | 146±17 | 148±20 | 0.338 |
| Median SBP (mmHg) | 145±18 | 147±21 | 0.373 |
| % SBPs >180 mmHg | 7.9% | 10.8% | 0.198 |
| % SBPs <90 mmHg | 0.4% | 0.8% | 0.444 |
| SBP Trajectory (mmHg change per day) | −3.3 | −0.1 | 0.135* |
| DIASTOLIC BLOOD PRESSURE | |||
| Mean DBP (mmHg) | 78±11 | 77±10 | 0.404 |
| Median DBP (mmHg) | 78±12 | 77±10 | 0.365 |
| % DBP >100 mmHg | 6.1% | 3.3% | 0.020* |
| % DBP <60 mmHg | 10.1% | 8.0% | 0.280 |
| DBP Trajectory (mmHg change per day) | −2.1 | −2.7 | 0.672 |
| ADDITIONAL HEMODYNAMICS | |||
| Mean MAP (mmHg) | 101±11 | 101±11 | 0.923 |
| MAP Trajectory (mmHg change per day) | −2.4 | −1.8 | 0.588 |
| LABORATORY VALUES AND COST DATA | |||
| SrCr Trajectory (mg/dL change per day) | −0.9 | −0.9 | 0.988 |
| Mean Glucose (mg/dL) | 143±36 | 147±42 | 0.358 |
| % Glucose >250 mg/dL | 5.1% | 7.0% | 0.092* |
| % Glucose <70 mg/dL | 1.6% | 1.7% | 0.913 |
| Mean Tacrolimus Trough Level (ng/mL) | |||
| Post-Transplant Day 3 | 5.1±3.3 | 5.3±3.0 | 0.506 |
| Post-Transplant Day 7 | 8.4±3.5 | 8.4±3.4 | 0.888 |
| Transplant Event Total Costs | $72,446±$17,444 | $65,706±$14,283 | 0.001* |
| Length of Stay (days) | 3.5±2.0 | 3.6±1.2 | 0.826 |
*
Included in the multivariate dynamic modeling (p≤0.2)